SOLID TUMOR MALIGNANCIES
Clinical trials for SOLID TUMOR MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR MALIGNANCIES trials appear
Sign up with your email to follow new studies for SOLID TUMOR MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cancer patients? early trial of ZE94-0605 begins
Disease control Not yet recruitingThis early-phase study tests an experimental drug called ZE94-0605 in about 60 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for any signs of tumor shrinkage. The study is not yet recruiting.
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: PHASE1 • Sponsor: Eilean Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New pill targets cancer growth pathway in advanced tumors
Disease control Not yet recruitingThis study tests a new drug called TYK-01054 for people with advanced solid tumors that have not responded to standard treatments. The drug is taken as a capsule and works by blocking a protein (TEAD) involved in cancer growth. The trial will check safety, find the best dose, and…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: TYK Medicines, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Custom mRNA vaccine takes on Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase trial tests a personalized mRNA vaccine called RH125 in 36 people with advanced solid tumors who have no standard treatment options left. The vaccine is custom-made based on each patient's tumor mutations and is given alone or with a PD-1 blocker. The main goals …
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center • Aim: Disease control
Last updated Jun 26, 2026 19:21 UTC
-
New imaging agent aims to light up hidden tumors
Diagnosis Not yet recruitingThis early-stage study will test a new radioactive tracer called [89Zr]DFO-YS5 in 40 people with nerve sheath tumors, bladder cancer, or other advanced solid tumors. The tracer is designed to bind to cancer cells and show up on PET scans, potentially making tumors easier to see. …
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: PHASE1 • Sponsor: Robert Flavell, MD, PhD • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Could a simple fruit acid boost cancer treatment?
Symptom relief Not yet recruitingThis early-phase study tests whether adding malic acid (a natural fruit acid) to standard immunotherapy is safe for people with solid tumors like colorectal, lung, or melanoma cancer. About 30 participants will take malic acid by mouth while continuing their immunotherapy. The ma…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Scientists hunt for biological clues to Cancer-Related anxiety and depression
Knowledge-focused Not yet recruitingThis study looks for biological markers in tumor tissue and blood that may be linked to anxiety and depression in people with solid tumors. Researchers will combine psychological assessments with lab tests to better understand these emotional struggles. The goal is to improve ear…
Matched conditions: SOLID TUMOR MALIGNANCIES
Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New study aims to predict dangerous immunotherapy side effects before they happen
Knowledge-focused Not yet recruitingThis study will collect blood and swab samples from 160 adults with solid tumors who are about to start immunotherapy. The goal is to find a biological 'signature' that can predict which patients will develop severe immune-related side effects. If such a signature is found, it co…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC